Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study

Emilio Iannitto, Monica Balzarotti, Maurizio Martelli, Pier Luigi Zinzani, Alessandra Tucci, Alice Di Rocco, Federica Cavallo, Sara Usai, Anna Guidetti, Emanuele Ravano, Franceso Merli, Barbara Botto, Matteo Pelosini, Cristina Tecchio, Michele Spina, Enrico Derenzini, Silvia Finotto, Brunella Mola, Antonio Pinto, Manuela Zanni, Roberta Battistini, Stefan Hohaus, Irene Dogliotti, Guido Gini, Vittorio Ruggero Zilioli, Sonya De Lorenzo, Anna Dodero, Alessandro Broccoli, Alessandro Maggi, Clara Mannarella, Annalisa Chiarenza, Domenico Pastore, Pellegrino Musto, Caterina Stelitano, Francesco Di Raimondo, Nicola Cascavilla, Nicola Di Renzo, Marilena Salerno, Renato Scalone, Luca Nassi, Attilio Guarini, Caterina Patti, Vita Polizzi, Gabriella Amato, Giovannino Ciccone, Andrea Evangelista, Agostino La Porta, Angelo Genua, Donato Mannina, Ciro Maria Improta, Alessandro Re, Fabrizio Lo Presti, Rosalba Donatella Calogero, Maurizio Musso, Ugo Consoli

Blood (2023) 142 (Supplement 1): 986.

https://doi.org/10.1182/blood-2023-178197

Published: 2023

Journal Articles

Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL)

Blood (2023) 142 (Supplement 1): 1621.

https://doi.org/10.1182/blood-2023-181731

Published: 2023

Journal Articles

Efficacy and Safety of Ibrutinib in Relapsed or Refractory Marginal Zone Lymphomas: The “Real World” Italian Experience

Blood (2023) 142 (Supplement 1): 1680.

https://doi.org/10.1182/blood-2023-182347

Published: 2023

Journal Articles

Prophylaxis with Intrathecal Chemotherapy and High Dose Methotrexate in Patients with Diffuse Large B Cell Lymphoma at High Risk for Central Nervous System Relapse: A Single Centre Experience

Dario Marino, MD PhD, Silvia Finotto, MD, Caterina Boso, MD, Federica Vianello, MD, Benedetta Chiusole, MD, Marco Pizzi, MD, Paola Fogar, MD, Vittorina Zagonel, MD

Blood (2018) 132 (Supplement 1): 5420.

https://doi.org/10.1182/blood-2018-99-119164

Published: 2018

Journal Articles

Efficacy of Radiation Treatement in Ocular Adnexa Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Evaluation in a Single Center Experience

Dario Marino, MDPhD, Maital Bolshinsky, MD, Silvia Finotto, MD, Raffaele Parrozzani, MD, Caterina Boso, MD, Federica Vianello, MD, Edoardo Midena, MD, Luca Canziani, MD, Laura Evangelista, MD, Vittorina Zagonel, MD

Blood (2017) 130 (Supplement 1): 2781.

https://doi.org/10.1182/blood.V130.Suppl_1.2781.2781

Published: 2017

Journal Articles

Comprehensive Geriatric Assessment (CGA) and ONCO-Mpi Predict Mortality in Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: A Retrospective Evaluation in a Single Center Experience

Silvia Finotto, MD, Dario Marino, Caterina Boso, MD, Filippo Marino, MD, Luca Canziani, MD, Giulia Bega, MD, Annunziata Lettiero, Miriam Farina, Antonella Brunello, MD, Vittorina Zagonel, MD

Blood (2016) 128 (22): 4206.

https://doi.org/10.1182/blood.V128.22.4206.4206

Published: 2016

Journal Articles

Rituximab, Bendamustine and Cytarabine (RBAC500) As Induction Therapy in Elderly Patients with Mantle Cell Lymphoma: Final Results of a Phase 2 Study from the Fondazione Italiana Linfomi

Blood (2016) 128 (22): 472.

https://doi.org/10.1182/blood.V128.22.472.472

Published: 2016

Journal Articles

Efficacy and Safety of Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Analysis of a Prospective, Randomized, Single-Blind, Placebo-Controlled Trial (EQoL-MDS)

Esther Natalie Oliva, MD, Valeria Santini, MD, Gina Zini, Giuseppe A Palumbo, Antonella Poloni, MD, Agostino Cortelezzi, MD, Maria Teresa Voso, Alfredo Molteni, Grazia Sanpaolo, MD, Antonio Marino, Filippo Rodà, MD, Caterina Alati, Francesca Ronco, Francesco Di Raimondo, Pietro Leoni, MD, Giuliana Alimena, Silvia Finotto, Roberto Latagliata, MD, Francesco Nobile, MD

Blood (2012) 120 (21): 923.

https://doi.org/10.1182/blood.V120.21.923.923

Published: 2012

Journal Articles

Rituximab, Bendamustine and Cytarabine (R-BAC) Is a Very Active Regimen In Patients with Mantle Cell Lymphoma Not Eligible for Intensive Chemotherapy or Autologous Transplant

Carlo Visco, MD, Renato Zambello, Rossella Paolini, Silvia Finotto, Roberta Zanotti, Francesco Zaja, Gianpaolo Nadali, MD, Livio Trentin, Elisabetta Rodella, Laura Lissandrini, Gianpietro Semenzato, MD, Giovanni Pizzolo, Francesco Rodeghiero, MD

Blood (2011) 118 (21): 2677.

https://doi.org/10.1182/blood.V118.21.2677.2677

Published: 2011

Journal Articles

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

Blood (2008) 112 (3): 844–847.

https://doi.org/10.1182/blood-2008-01-135897

Published: 2008

Includes: Supplemental data

Journal Articles

Jak2 Exon 12 Mutational Status in a Cohort of Idiopathic Erithrocytosis V617F Negative Patients.

Martina Bernardi, BIOL. SCI, Marco Ruggeri, MD, Elena Albiero, BIOL. SCI, Domenico Madeo, BIOL. SCI, Silvia Finotto, MD, Francesco Rodeghiero, MD

Blood (2007) 110 (11): 4648.

https://doi.org/10.1182/blood.V110.11.4648.4648

Published: 2007

NARROW

Description of a Clinical Score to Identify PMBL Patients at High Risk of Early-Failure after Rituximab Doxorubicin Back-Bone Chemoimmunotherapy. a FIL Real-World Study

Prospective Evaluation of Minimal Residual Disease in Waldenström Macroglobulinemia across Different Tissues and Treatments: Results of the “BIO-WM” Trial of the Fondazione Italiana Linfomi (FIL)

Efficacy and Safety of Ibrutinib in Relapsed or Refractory Marginal Zone Lymphomas: The “Real World” Italian Experience

Prophylaxis with Intrathecal Chemotherapy and High Dose Methotrexate in Patients with Diffuse Large B Cell Lymphoma at High Risk for Central Nervous System Relapse: A Single Centre Experience

Efficacy of Radiation Treatement in Ocular Adnexa Mucosa-Associated Lymphoid Tissue Lymphoma: A Retrospective Evaluation in a Single Center Experience

Comprehensive Geriatric Assessment (CGA) and ONCO-Mpi Predict Mortality in Diffuse Large B-Cell Lymphoma (DLBCL) in the Elderly: A Retrospective Evaluation in a Single Center Experience

Rituximab, Bendamustine and Cytarabine (RBAC500) As Induction Therapy in Elderly Patients with Mantle Cell Lymphoma: Final Results of a Phase 2 Study from the Fondazione Italiana Linfomi

Efficacy and Safety of Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Analysis of a Prospective, Randomized, Single-Blind, Placebo-Controlled Trial (EQoL-MDS)

Rituximab, Bendamustine and Cytarabine (R-BAC) Is a Very Active Regimen In Patients with Mantle Cell Lymphoma Not Eligible for Intensive Chemotherapy or Autologous Transplant

Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia

Jak2 Exon 12 Mutational Status in a Cohort of Idiopathic Erithrocytosis V617F Negative Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only